Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M701197200 on March 16, 2007

J. Biol. Chem., Vol. 282, Issue 20, 15040-15047, May 18, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/20/15040    most recent
M701197200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xhemalce, B.
Right arrow Articles by Arcangioli, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xhemalce, B.
Right arrow Articles by Arcangioli, B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of Histone H3 Lysine 56 Acetylation in Schizosaccharomyces pombe*Formula

Blerta Xhemalce{ddagger}§1, Kyle M. Miller, Robert Driscoll2, Hiroshi Masumoto||3, Stephen P. Jackson4, Tony Kouzarides§4, Alain Verreault**5, and Benoît Arcangioli{ddagger}6

From the {ddagger}Unité de la Dynamique du Génome, Institut Pasteur, 25 rue du Dr. Roux, 75724, Paris Cedex 15, France, **Institut de Recherche en Immunologie et Cancérologie, Université de Montréal, CP 6128, Succursale Centre-Ville, Montréal, Québec H3C 3J7, Canada, §The Wellcome Trust and Cancer Research and Department of Pathology, Tennis Court Road, Cambridge CB2 1QN, United Kingdom, The Wellcome Trust and Cancer Research Gurdon Institute and the Department of Zoology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, United Kingdom, and ||Laboratories for Biomolecular Networks, Graduate School of Frontier Biosciences, Osaka University, 1-3 Yamada-oka, Suita, Osaka 565-0871, Japan

Received for publication, February 8, 2007 , and in revised form, March 15, 2007.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In Saccharomyces cerevisiae, acetylation of lysine 56 (Lys-56) in the globular domain of histone H3 plays an important role in response to genotoxic agents that interfere with DNA replication. However, the regulation and biological function of this modification are poorly defined in other eukaryotes. Here we show that Lys-56 acetylation in Schizosaccharomyces pombe occurs transiently during passage through S-phase and is normally removed in G2. Genotoxic agents that cause DNA double strand breaks during replication elicit a delay in deacetylation of histone H3 Lys-56. In addition, mutant cells that cannot acetylate Lys-56 are acutely sensitive to genotoxic agents that block DNA replication. Moreover, we show that Spbc342.06cp, a previously uncharacterized open reading frame, encodes the functional homolog of S. cerevisiae Rtt109, and that this protein acetylates H3 Lys-56 both in vitro and in vivo. Altogether, our results indicate that both the regulation of histone H3 Lys-56 acetylation by its histone acetyltransferase and histone deacetylase and its role in the DNA damage response are conserved among two distantly related yeast model organisms.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Histone acetylation corresponds to the covalent attachment of an acetyl group to a lysine residue. This modification is mediated by histone acetyltransferases (HATs)7 and is reversible as the acetyl group can be removed through the action of histone deacetylases (HDACs). Lysine acetylation on histones is best characterized for its role in transcriptional regulation, but evidence for a crucial function during replication and DNA damage tolerance is accumulating (1–3). Indeed, newly synthesized histones that are deposited throughout the genome during replication are transiently acetylated at several lysine residues (4, 5). These include sites of acetylation in the N-terminal tails of both histones H3 and H4 (6–8). Recently, two novel sites of acetylation in the globular domains of newly synthesized histone molecules were uncovered by mass spectrometry of Saccharomyces cerevisiae histones, lysine 91 (Lys-91) of histone H4 (9) and lysine 56 (Lys-56) of histone H3 (10–15).

H3 Lys-56 acetylation (H3 Lys-56-Ac) shows a particular link between DNA replication and DNA damage tolerance. In budding yeast, this modification occurs concomitantly with DNA replication as virtually all the newly synthesized histone H3 molecules deposited throughout the genome are Lys-56-acetylated, whereas in the G2/M-phase of the cell cycle the vast majority of H3 Lys-56 is deacetylated (11, 15–17). However, in response to DNA breaks during replication, histone H3 Lys-56 acetylation is maintained in a DNA damage checkpoint-dependent manner. In S. cerevisiae this modification plays a key role in surviving DNA damage as cells in which histone H3 cannot be acetylated at Lys-56 are acutely sensitive to genotoxic agents that interfere with DNA replication (10–13).

The deacetylation of H3 Lys-56 requires the Sir2-related HDACs Hst3 and Hst4 (16, 17). Hst3 and Hst4 are cell cycles regulated with peak expression occurring in G2/M and M/G1, respectively. Interestingly, the persistence of H3 Lys-56-Ac in response to damage is dependent upon the DNA damage checkpoint, which represses the transcription of the HST3/HST4 genes thereby maintaining high levels of H3 Lys-56-Ac (11, 17). In cells lacking both Hst3 and Hst4, histone H3 is almost fully acetylated at Lys-56 (98%) during the entire cell cycle. This results in thermosensitivity, severe sensitivity to genotoxic agents, increased levels of mitotic chromosome loss, and a high incidence of spontaneous DNA damage (16, 17).

Until recently, the HAT responsible for H3 Lys-56 acetylation was unknown leaving a gap in fully understanding the regulation of this mark. This was because of the fact that yeast mutants of enzymes with recognizable HAT motifs are not defective in H3 Lys-56 acetylation (12). Very recently, this gap was filled by the discovery of the HAT responsible for H3 Lys-56-Ac (18–21). Deletion of RTT109, a gene previously described as a regulator of Ty1 transposition, results in the loss of H3 Lys-56-Ac. Rtt109 represents the founding member of a new family of HATs that lack any discernible motifs, such as an acetyl-CoA binding site, found in all previously described HATs. In vitro data show that Rtt109 has a high specificity for H3 Lys-56 suggesting that this histone residue is its main substrate. Additionally, similar to cells unable to acetylate H3 Lys-56 (i.e. H3 K56R), rtt109{Delta} mutants display sensitivity to replicate stress (18, 19, 21). Interestingly, loss of the H3/H4 histone chaperone ASF1 also results in the absence of H3 Lys-56-Ac (13, 16, 18, 19, 21, 22). Taken together, these data suggest an intimate, but poorly understood, functional relationship between Rtt109, Asf1, and H3 Lys-56-Ac.

Interestingly, histone H3 Lys-56 acetylation has been reported in embryo-derived Drosophila S2 cells as well as transcriptionally active polytene chromosomes (14, 20), but paradoxically not in human HeLa cells (12, 14). To determine whether histone H3 Lys-56 acetylation is conserved in other eukaryotes, we investigated the presence and the regulation of this modification in Schizosaccharomyces pombe, which is estimated to have diverged from S. cerevisiae between 320 and 420 million years ago, making fission and budding yeast as distantly related to each other as mammals are to either yeast (23). In this manuscript, we demonstrate that histone H3 Lys-56 acetylation in S. pombe occurs transiently during S-phase, but is maintained in response to genotoxic agents that interfere with DNA replication. We also provide evidence that H3 Lys-56-Ac is catalyzed by a fission yeast orthologue of S. cerevisiae Rtt109 and that the absence of Rtt109 or the H3 K56R mutation confers sensitivity to genotoxic agents. Thus, both the cell cycle and DNA damage regulation of histone H3 Lys-56 acetylation are conserved in S. pombe.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Fission Yeast Strains, Plasmids, Media, and Methods—The S. pombe strains used in this study are listed in Table 1. Growth, maintenance, and standard genetic methods for fission yeast strains were as described (49). Details about strain construction are available upon request.


View this table:
[in this window]
[in a new window]

  		TABLE 1
Fission yeast strains

 
Synchronization Conditions—Cells exponentially grown in YES medium at 33 °C were synchronized using lactose gradients as described previously (24), except that three consecutive lactose gradient centrifugations were performed. Small G2 cells were resuspended in pre-warmed YES medium at 33 °C at an initial concentration of 2.5 x 106 cells/ml.

Preparation of S. pombe Whole-Cell Extracts (WCE) and Western Blot Analysis—2 x 107 cells were harvested, washed with ice-cold water, and frozen at -80 °C until WCE were prepared. The pellets were thawed on ice, washed in 20% trichloroacetic acid, and resuspended in 200 µl of 20% trichloroacetic acid. After cells were broken with glass beads, 400 µl of 5% trichloroacetic acid was added, and the cell lysate was spun into a new test tube. Following centrifugation at 13,000 rpm for 10 min, the supernatant was discarded, and the pellet was resuspended in 80 µl of loading buffer and heated for 5 min at 95 °C. 10 µl of WCE was separated in SDS-15% polyacrylamide gels and analyzed by Western blotting using the indicated rabbit primary antibodies and a horseradish peroxidase-conjugated anti-rabbit IgG secondary antibody (Amersham Biosciences). The anti-H3-Lys-56-Ac and anti-{gamma}-H2A antibodies are described previously (11, 16). A rabbit polyclonal antibody against the unmodified histone H3 N-terminal tail was raised against a synthetic peptide (H3N, residues 1–41 of S. cerevisiae histone H3) coupled to maleimide-activated keyhole limpet hemocyanin (Perbio) via an N-terminal cysteine residue. Antibodies against the H3 N-terminal domain were isolated from the crude serum by affinity purification over a SulfoLink column (Perbio) to which the H3N peptide was covalently linked via the N-terminal cysteine. Antibodies were eluted from the H3N peptide column using gentle Ag/Ab elution buffer (Perbio), dialyzed against phosphate-buffered saline and stored at -20 °C in the presence of 10% glycerol.

HAT Activity Assay—Experiments were performed as described previously (18). SpRtt109 was amplified by PCR from S. pombe genomic DNA and cloned into the N-terminal His6 tagging bacterial expression vector pET28a. Proteins were purified as described (18). Recombinant ScRtt109 and ScAsf1 were kindly provided by the Jackson laboratory. Reactions contained 100 ng of recombinant yeast H3 and either 2000 ng of SpRtt109, 600 ng of ScAsf1, 1200 ng of SpRtt109, or a mock control. H3 alone and ScRtt109 plus 800 ng of bovine serum album were also analyzed for controls. Reactions were incubated for 45 min at 30 °C. HAT activity assays were performed as stated in the legend of Fig. 3.


Figure 1
View larger version (27K):
[in this window]
[in a new window]

  		FIGURE 1.
Fission yeast histone H3 is acetylated at lysine 56. A, sequence alignment of the {alpha}N helices of histone H3 derived from S. cerevisiae (Sc), S. pombe (Sp), D. melanogaster (Dm), and Homo sapiens (Hs). In Drosophila and human cells, Lys-56 is present in both replication-dependent (H3.1) and replication-independent histone H3 (H3.3). B, WCE from WT fission yeast cells (PB10) were analyzed by Western blotting with the {alpha} H3-Lys-56-Ac antibody in the presence of a 1000-fold molar excess of H3 (52–64) peptides that were either acetylated or not modified at Lys-56. C, WCEs were prepared from WT cells (PB10) or cells containing a single copy of histone H3 gene encoding Lys (FY4640), Arg (SPBX84), or Gln (SPBX85) at residue 56. Western blots were probed with the {alpha} H3-Lys-56-Ac or the {alpha} N-terminal H3 antibody as a loading control. The asterisk indicates a cross-reacting band.

 

   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Fission Yeast Histone H3 Is Acetylated at Lys-56—The amino acid residues flanking Lys-56 in histone H3 are highly conserved (Fig. 1A). Thus, it seemed likely that antibodies raised against Lys-56-acetylated H3 from S. cerevisiae might also be used to explore the presence of this modification in other species. In S. pombe whole-cell lysates, this antibody detected a single polypeptide in the presence of a 1000-fold molar excess of competitor peptide lacking Lys-56 acetylation (Fig. 1B). In contrast, the same molar excess of Lys-56-acetylated peptide completely eliminated the signal detected by our antibody (Fig. 1B). To provide further evidence for its specificity, we generated S. pombe strains where the only source of histone H3 carried a mutation changing Lys-56 into either an arginine (R) or a glutamine (Q), which could not be acetylated. These mutants were viable, showing that the acetylation of H3 Lys-56 was not essential for cellular survival. The signal detected in wild-type (WT) cells was absent from both mutant strains (Fig. 1C). Thus, our antibody specifically detected acetylated H3 Lys-56 in S. pombe. Despite the strong evolutionary conservation of the residues flanking H3 Lys-56, there is a single amino acid sequence difference between S. cerevisiae and other species (Fig. 1A). In S. cerevisiae histone H3, a phenylalanine located just two residues before the acetylated Lys-56 is replaced by a tyrosine in S. pombe, Drosophila melanogaster, and human cells (Fig. 1A). The fact that our antibody raised against an S. cerevisiae peptide readily detects H3 Lys-56 acetylation in S. pombe argues that the presence of a tyrosine residue at position 54 does not preclude detection of Lys-56 acetylation in Western blots. Thus, because the sequence flanking Lys-56 is identical in S. pombe and human cells, our failure to detect the acetylation in HeLa cells (data not shown) cannot be merely because of the substitution of the S. cerevisiae phenylalanine by a tyrosine. Therefore, if H3 Lys-56 acetylation does exist in human cells, it must be present at significantly lower stoichiometry than in S. pombe and S. cerevisiae. Alternatively, H3 Lys-56 acetylation-specific antibodies may be impeded by modification of adjacent residues or Lys-56 itself. For instance, methylation of H3 Lys-56 has been reported in murine cells (25), and a monomethylation of histone H3 Arg-52, Arg-53, or Arg-56 has been detected by mass spectrometry in bovine histones (26). However, there was no attempt to prove that this methylation occurred in H3 Lys-56 as opposed to the arginine residues.

Lys-56 Histone H3 Acetylation Is Restricted to S-phase in Normal Cells but Persists in Response to Camptothecin Treatment—Having established its specificity, we used our antibody to determine the regulation of histone H3 Lys-56 acetylation during the cell cycle. A population of small G2 cells was isolated by lactose gradient centrifugation (24). These cells were returned to rich medium at 33 °C, and the septation index was monitored by microscopy to determine when cells entered S-phase (Fig. 2B). A sharp increase in H3 Lys-56 acetylation occurred between 30 and 45 min, concomitant with a rise in the fraction of septated cells (Fig. 2A). This acetylation was transient and subsequently declined between the 90- and 105-min time points, coinciding with the disappearance of septated cells. Progression through S-phase was also monitored using an antibody against histone H2A phosphorylated at Ser-128 ({gamma}-H2A) that, even in untreated cells, detects spontaneous damage during normal passage through S-phase (16, 27). The Lys-56 acetylation signal coincided with a transient {gamma}-H2A signal in untreated cells (Fig. 2, {gamma}-H2A, long exposure). Thus, as observed in S. cerevisiae (11, 15), H3 Lys-56 acetylation is confined to S-phase during normal cell cycle progression in S. pombe.To induce S-phase damage, we treated cells with camptothecin (Cpt), a cancer therapeutic that functions to stabilize the covalent intermediate between topoisomerase I and DNA, generating single strand breaks that can be transformed into double strand breaks during replication (28). When cells were treated with 15 µM Cpt 30 min after release from G2 (Fig. 2A), Lys-56 acetylation and {gamma}-H2A persisted for at least 120 min, long after these histone modifications had vanished from control cells that were not treated with Cpt (Fig. 2A). This was also observed when cells were synchronized using a cdc10ts mutation (29) and treated with the alkylating agent methylmethane sulfonate (MMS), which also induced replicative DNA damage (supplemental Fig. S1). Furthermore, when WT cells were treated with MMS, levels of H3 Lys-56 acetylation were increased (Fig. 3B). Thus, the persistence of H3 Lys-56 acetylation seems to be a physiological response to DNA damage during replication.


Figure 2
View larger version (43K):
[in this window]
[in a new window]

  		FIGURE 2.
Lys-56 histone H3 acetylation is restricted to S-phase in normal cells but persists in response to Cpt treatment. A, WT cells (PB10) were synchronized using a lactose gradient procedure that enriches for small G2 cells, and after 30 min at 33 °C, Cpt was added at 15 µM to a fraction of the culture. WCEs of cells harvested at the indicated time points were analyzed by Western blotting with the {alpha} H3-Lys-56-Ac, {alpha} N-terminal H3 and {alpha}{gamma}H2A antibodies. The percentage of septated cells and a long exposure of the {gamma}H2A blot are shown as markers of S-phase progression. The asterisks indicate a cross-reacting band that does not fluctuate during the cell cycle. B, diagram showing the correlation between cell cycle progression and morphology of S. pombe cells.

 
Spbc342.06cp Encodes SpRtt109 and Acetylates H3 Lys-56 Both in Vitro and in Vivo—Until very recently, the HAT responsible for acetylating H3 on Lys-56 was unknown. Although work describing the identification of Rtt109 as the HAT in budding yeast was ongoing (18), we searched the S. pombe genome data base for homologs of ScRtt109. One uncharacterized open reading frame, Spbc342.06cp, showed 27% identity with ScRtt109 (Fig. 3A). We sought to explore the relationship between this gene and H3 Lys-56 acetylation. Targeted gene deletion of Spbc342.06cp resulted in viable cells showing that this gene was non-essential. Western blot analysis showed loss of H3 Lys-56 acetylation in the spbc342.06cpD mutant, even after MMS-induced DNA damage, which increased the levels of H3 Lys-56-Ac in WT cells (Fig. 3B). We also analyzed cells deleted for hst4+, the putative homolog of the budding yeast Sir2-related HDACs HST3 and HST4, which target H3 Lys-56 for deacetylation. Indeed, loss of hst4+ resulted in hyperacetylation of H3 Lys-56-Ac, indicating that Hst4 function was conserved. Interestingly, MMS treatment of hst4{Delta} cells had little effect on H3 Lys-56-Ac; consistent with the finding that loss of HST3 and HST4 in budding yeast results in nearly complete acetylation of H3 Lys-56 throughout the cell cycle (16, 17).

To establish whether the effect of loss of Spbc342.06cp on H3 Lys-56-Ac was direct, we employed an in vitro HAT activity assay using recombinant Spbc342.06cp protein expressed in E. coli. As a positive control, we used recombinant ScRtt109, which has been shown to acetylate H3 Lys-56 in vitro (18, 19, 21). Like ScRtt109, the Spbc342.06cp protein was able to acetylate H3 in vitro (Fig. 3C, Autoradiograph). Further analysis with an antibody against H3 Lys-56-Ac showed that H3 Lys-56 was acetylated by the Spbc342.06cp protein in the reaction (Fig. 3C, Western). Thus, both our in vivo and in vitro results strongly suggest that Spbc342.06cp is the functional homolog of ScRtt109. Therefore, we have now designated the Spbc342.06cp open reading frame Sprtt109+. Interestingly, SpRtt109 was also able to self-acetylate (Fig. 3C, Autoradiograph). The biological significance of this modification is unknown. However, its conservation between the two yeasts (18, 19, 21) suggests it could be important to regulate this novel family of HAT enzymes. Additionally, Rtt109 is acetylated in vivo thus supporting this hypothesis (21).

Histone H3 Lys-56 Acetylation Is Required for S-phase Linked DNA Damage Tolerance and Proper Centromeric Silencing—To determine whether S. pombe cells require Lys-56-Ac to survive genotoxic agents, we examined the sensitivity of H3-K56R, rtt109{Delta}, and H3-K56R/rtt109{Delta} double mutant cells under a variety of DNA damaging conditions (Fig. 4B). The three mutant strains were not sensitive to lesions created by short wavelength ultraviolet light radiation and only mildly sensitive to ionizing radiation, which generated lesions that were mainly repaired during the G2 phase of the cell cycle in S. pombe. In contrast, each single mutant was sensitive to a number of genotoxic agents that cause both single and double strand DNA breaks during replication, including Cpt (data not shown), MMS, and hydroxyurea, an inhibitor of ribonucleotide reductase that stalls DNA replication forks by depleting deoxyribonucleoside triphosphates (30). Interestingly, the H3-K56R/rtt109{Delta} mutant was no more sensitive than either single mutant, showing that SpRtt109 and H3 Lys-56-Ac function in the same pathway for DNA damage tolerance. However, the rtt109{Delta} mutant was less sensitive to MMS than the H3-K56R or H3-K56R/rtt109{Delta} mutants. The simplest explanation is that the K56R mutation is more deleterious for MMS sensitivity than an unacetylated H3 Lys-56, for example by blocking another type of modification. Alternatively, there may be a low level of residual acetylation of H3 Lys-56 that is Rtt109-independent.

We further analyzed the effect of mutants lacking H3 Lys-56-Ac on heterochromatic silencing. In fission yeast, the centromeres are large DNA structures (40–100 kb) composed of central regions (innermost repeat (imr) and central (cnt)) and outer repetitive regions (otr) corresponding to the pericentromeric heterochromatin (Fig. 4A). We made use of a strain containing an ade6+ gene inserted at otr1R, which allowed us to assay silencing by the color of the colonies (Fig. 4A) (31). WT cells formed red colonies indicating repression of the inserted centromeric ade6+ gene. However, H3-K56R, rtt109{Delta}, and the H3-K56R/rtt109{Delta} mutant cells formed colonies of variable pink indicating a slight decrease in silencing at centromeres (Fig. 4A). This might indicate a cross-talk of H3 Lys-56-Ac with the establishment or the maintenance of other activating or repressing histone modifications required for proper centromeric heterochromatin formation.


Figure 3
View larger version (56K):
[in this window]
[in a new window]

  		FIGURE 3.
Spbc342.06cp encodes SpRtt109 and acetylates H3 Lys-56 both in vitro and in vivo. A, alignment of the S. pombe SpRtt109 encoded by Spbc342.06cp and the S. cerevisiae ScRtt109 using the CLUSTAL W algorithm and Boxshade. Identical residues and gaps are in black and similar residues are in gray. B, WCE from logarithmically growing WT (FY4640), H3-K56R (SPBX84), rtt109{Delta} (SPBX86), and hst4{Delta} (LPY3278) cells not treated (Asy) or treated with 0.010% MMS for 3 h were analyzed by Western blotting with {alpha} H3-Lys-56-Ac and {alpha} H3 antibodies. C, recombinant ScRtt109, ScAsf1, and SpRtt109 were purified and analyzed in a HAT assay toward histone H3 using [3H]acetyl-CoA. Reactions of ScRtt109, ScAsf1, mock, and SpRtt109 incubated with H3 as well as H3 alone and SpRtt109 plus bovine serum albumin are shown. One-quarter of the reaction was analyzed on a 15% polyacrylamide gel by Coomassie Brilliant Blue staining (top gel) and autoradiography (bottom gel). Another quarter of the sample was analyzed by Western blotting and probed for total H3 and H3 Lys-56-Ac. The rest of the sample was used in a liquid scintillation counter to measure [3H]acetate incorporation into protein. The mean and standard deviation of four independent experiments are shown in the graph.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
In this manuscript, we demonstrate that histone H3 Lys-56 acetylation in S. pombe promotes cell survival in response to genotoxic agents that interfere with DNA replication (Fig. 4). Histone H3 Lys-56 acetylation occurs through de novo nucleosome assembly during normal passage through S-phase (Fig. 2) (11, 15). In normal cells, the acetylation is transient and removed during the G2 phase of the cell cycle. In both S. pombe and S. cerevisiae, the period of time in which H3 Lys-56 acetylation can be detected is extended in response to DNA breaks created by camptothecin (Fig. 2) and other DNA damaging agents (Fig. 3B and supplemental Fig. S1) (11, 17). This prolonged delay in deacetylation of H3 Lys-56 is likely to be important for increasing the window of time in which Lys-56 acetylation can perform its function in response to DNA damage. In S. cerevisiae, the DNA damage-induced persistence of H3 Lys-56 acetylation is achieved by the DNA damage checkpoint (11, 17). The checkpoint proteins act, at least in part, by preventing the activation of the HST3 and HST4 genes, which encode enzymes that promote deacetylation of H3 Lys-56 (17). This is conserved in fission yeast as deletion of hst4+, the single gene homologous to S. cerevisiae HST3/HST4, results in hyperacetylation of H3 Lys-56 (Fig. 3B). This is consistent with the fact that expression of the S. pombe hst4+ gene suppresses the strong thermosensitive and telomeric silencing phenotypes of S. cerevisiae hst3hst4 mutants, which are known to result from hyperacetylation of H3 Lys-56 (16, 17, 32). This suggests that Hst4 promotes deacetylation of H3 Lys-56 in S. pombe. Our result showing that Cpt-induced DNA damage leads to a prolonged delay in H3 Lys-56 deacetylation suggests that the role of the DNA damage checkpoint in controlling the expression and/or the activity of the enzymes that deacetylate H3 Lys-56 is likely conserved between these two yeasts.


Figure 4
View larger version (40K):
[in this window]
[in a new window]

  		FIGURE 4.
Histone H3 lysine 56 acetylation is required for S-phase-linked DNA damage tolerance and proper silencing in pericentromeric heterochromatin. A, the diagram shows the structure of the S. pombe centromere 1 and the site of the ade6+ gene insertion used for the colony color silencing assay. Logarithmically growing WT (FY4640), H3-K56R (SPBX84), rtt109{Delta} (SPBX86), and H3-K56R/rtt109{Delta} (SPBX87) cells containing the ade6+ gene inserted at otr1R were spotted onto plates containing medium with limited adenine (YE). B, 5-fold serial dilutions of WT (FY4640), H3-K56R (SPBX84), rtt109{Delta} (SPBX86), and H3-K56R/rtt109{Delta} (SPBX87) cells were spread onto YES medium lacking or containing the indicated amounts of genotoxic agents. Plates were incubated at 30 °C until full growth was achieved. For UV and {gamma}-ray sensitivity, cells were spread onto YES medium and then irradiated as indicated.

 
The discovery of the novel HAT, Rtt109, that acetylates H3 on Lys-56 in budding yeast and now in fission yeast, has completed the description of the enzymatic reactions that can regulate acetylation of H3 Lys-56 (18, 19, 21). Loss of ScRtt109 results in an increase in genomic instability as assayed by persistent Rad52 foci, Rad53 phosphorylation, and an increase in gross chromosomal rearrangements (18, 19). ScRtt109 is involved in surviving replicative DNA damage as rtt109 mutants in S. cerevisiae are sensitive to a wide array of DNA damaging agents that induce S-phase specific damage, but surprisingly not ionizing radiation, a treatment that mainly induces DNA breaks outside of S-phase. We also found that Sprtt109{Delta} mutants were sensitive to replicative stress (Fig. 4B) with the difference that Sprtt109{Delta} mutants were mildly sensitive to ionizing radiation. This might reflect a difference in cell cycle progression between the two yeasts. Fission yeast cells spend most of their time in G2, whereas budding yeast cells lack a discernable G2 phase of the cell cycle, suggesting that regulation of H3 Lys-56-Ac could be important in G2 in S. pombe.

We find that H3-K56R and Sprtt109{Delta} mutants are moderately defective in silencing at pericentromeric heterochromatin, a biological process not found in S. cerevisiae. Thus, H3 Lys-56-Ac regulation appears to be involved in heterochromatin formation and/or stability in S. pombe. However, H3 Lys-56-Ac and Rtt109 are shown to be associated with some actively transcribed genes in S. cerevisiae, suggesting a link with transcriptional regulation (14, 20). Interestingly, RNA polymerase II-dependent transcription is required for initiating RNA interference-dependent silencing at the pericentromeric heterochromatin in S. pombe (33). Therefore, the silencing defects observed in the H3-K56R and Sprtt109{Delta} could result from defective transcription. Alternatively, they could be because of defective replication, a process also linked to proper heterochromatin formation (34).

Scrtt109{Delta} mutants are synthetic lethal with hypomorphic mutations in proliferating cell nuclear antigen as well as polymerase-{alpha}, two genes involved in DNA replication (19). These data suggest that DNA damage generated by perturbation of the replisome requires Rtt109 and H3 Lys-56-Ac for survival. Many of these phenotypes are shared by mutants that lack Asf1, an H3/H4 histone binding chaperone (13, 35–37). This phenotypic similarity was recently explained by the finding that Asf1 is also required for H3 Lys-56-Ac (13). Interestingly, Asf1 stimulates the HAT activity of Rtt109, although no physical interaction between the two proteins has been found (18). In S. pombe, like in vertebrates, cia1, the homolog of ASF1, is essential for viability (38, 39). Therefore, Cia1 appears to have a crucial function not shared by H3 Lys-56-Ac, as Sprtt109{Delta} cells are viable. In budding yeast, Asf1 binds the checkpoint kinase Rad53, but this function is not conserved in mammalian cells (39–41). Therefore, S. pombe may be a better model system to understand the essential role of Asf1/Cia1. Regardless, the finding that mutations in these genes are epistatic with the unacetylable H3 K56R mutation for surviving DNA damage (13, 18) suggests that the underlying cause of the phenotypes associated with rtt109{Delta} and asf1{Delta} is because of the inability of these strains to acetylate H3 at Lys-56.

H3 K56R mutant cells are acutely sensitive to several clastogens that, either directly or indirectly, generate DNA into double strand breaks during replication (Fig. 4B) (10–13). This sensitivity could result from defective homologous recombination, which is the major pathway for repairing replicative damage. Homothallic fission yeast cells switch their mating type by making use of a site-specific single-stranded lesion that is transformed into a double strand break during the passage of a unidirectional replication fork. This initiates a gene conversion event that replaces the mating type cassette at the active mating type locus (42–45). Therefore, we analyzed the effect of the absence of H3 Lys-56 acetylation in mating-type switching efficiency in S. pombe. Homothallic H3-K56R mutants did not show major defects in mating-type switching (data not shown) implying that H3 Lys-56 acetylation was not required for single gene conversions per se. This is in agreement with a previous finding that H3-K56R and rad52{Delta} mutations have additive effects on MMS sensitivity suggesting that the genes act in two separate genetic pathways in budding yeast (11). Furthermore, homologous recombination between sister chromatids is not severely impaired in asf1 mutants (35, 36, 46). Altogether the accumulated data strongly suggest that H3 Lys-56 acetylation is not required for homologous recombination.

During S-phase, Lys-56-acetylated H3 molecules are deposited behind replication forks throughout the genome (16). The acetylation of the Lys-56 side chain disrupts weak water-mediated contacts between histone H3 and DNA segments at the entry and exit points of the nucleosome core particle (47). Conceivably, this enhanced accessibility of short stretches of nucleosomal DNA could facilitate the action of proteins involved in replisome stabilization and/or the restart of stalled replication forks. Interestingly, several abnormal perturbations of the replisome occur when replication forks are blocked by dNTP depletion with hydroxyurea in S. cerevisiae asf1 mutants that lack H3 Lys-56 acetylation (48). In asf1 mutants, at least three key replication proteins (DNA polymerase {epsilon}, proliferating cell nuclear antigen, and RFC) dissociate from hydroxyureastalled forks. Conversely, DNA polymerase {alpha} abnormally accumulates at stalled forks (48). At least some of these replisome perturbations may lead to irreversible DNA damage and underlie the strong sensitivity of rtt109, asf1, and H3 K56R mutant cells to genotoxic agents that interfere with replication. Through a direct effect on chromatin structure, Lys-56 acetylation could, in principle, promote replication recovery without directly binding any protein. This might help to explain how a genome-wide modification such as H3 Lys-56 acetylation, can be exploited by cells to facilitate the repair of lesions that occur at stochastic sites during replication. However, the first double helical turns of DNA at the entry and exit points of the nucleosome rapidly bind to and dissociate from the histone surface even in the absence of Lys-56 acetylation (49, 50). Thus, it seems equally plausible that the function of H3 Lys-56 acetylation in response to DNA damage during replication might be exerted through the recruitment of effector proteins to sites of damaged replication forks.

Given that the acetylation of H3 Lys-56 by Rtt109, its deacetylation by sirtuin HDACs, and the role of H3 Lys-56 acetylation in the DNA damage response are conserved among two divergent yeast organisms, it is somewhat surprising that the modification has been detected in Drosophila but not in HeLa cells (12, 14). The acetylation of the N-terminal tails of newly synthesized histones is turned over very rapidly in human cells (4, 5). Therefore, the apparent absence of H3 Lys-56 acetylation in human cells could merely reflect technical limitations in detecting the small fraction of total histones that carry the modification. Additionally, because H3 Lys-56-Ac is found in Drosophila (14, 20), there must be an as-yet-unidentified HAT responsible for this histone modification. However, Rtt109 from fission and budding yeast define the only two members of this new family of HATs and do not share obvious homology with any proteins from higher eukaryotes. This suggests that the Drosophila enzyme has diverged in sequence, although its ability to acetylate H3 Lys-56 has been retained. Our findings that Rtt109 and H3 Lys-56-Ac are conserved in fission yeast raise the exciting possibility that this pathway may also exist in mammalian cells and that additional H3 Lys-56 acetyltransferases remain to be discovered.


   FOOTNOTES
 
* This work was supported by a fellowship from the Ministère de l'Education Nationale, de la Recherche et de la Technologie, and the Association pour la Recherche sur le Cancer (to B. X.) and a grant from the Human Frontiers Science Program (to B. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. S1. Back

2 Supported by United Kingdom Biotechnology and Biological Sciences Research Council Cooperative Awards in Science and Engineering studentship with KuDOS Pharmaceuticals and by a Cancer Research United Kingdom programme grant (to S. P. J.). Back

3 Supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Back

4 Supported by core infrastructure funding from Cancer Research United Kingdom and the Wellcome Trust. Back

5 Supported by the Association for International Cancer Research and the Canadian Institutes for Health Research. Back

1 To whom correspondence may be addressed. b.xhemalce{at}gurdon.cam.ac.uk. Tel.: 44-1223-334-111; Fax: 44-1223-334-089. 6 To whom correspondence may be addressed. barcan{at}pasteur.fr. Tel.: 33-1-4568-8454; Fax: 33-1-4568-8960.

7 The abbreviations used are: HAT, histone acetyltransferase; HDAC, histone deacetylase; H3 Lys-56-Ac, H3 Lys-56 acetylation; WCE, whole-cell extracts; WT, wild-type; Cpt, camptothecin; MMS, methylmethane sulfonate; pol, polymerase. Back


   ACKNOWLEDGMENTS
 
We thank Paul Nurse for the cdc10ts strain, Lorraine Pillus for the hst4{Delta} strain, Robin Allshire for the FY4754 and FY4640 strains, and Paul Kaufman for the Asf1 expression vector.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. van Attikum, H., and Gasser, S. M. (2005) Nat. Rev. Mol. Cell Biol. 6, 757-765[CrossRef][Medline] [Order article via Infotrieve]
  2. Ozdemir, A., Masumoto, H., Fitzjohn, P., Verreault, A., and Logie, C. (2006) Cell Cycle 5, 2602-2608[Medline] [Order article via Infotrieve]
  3. Miller, K. M., Maas, N. L., and Toczyski, D. P. (2006) Cell Cycle 5, 2561-2565[Medline] [Order article via Infotrieve]
  4. Jackson, V., Shires, A., Tanphaichitr, N., and Chalkley, R. (1976) J. Mol. Biol. 104, 471-483[CrossRef][Medline] [Order article via Infotrieve]
  5. Ruiz-Carrillo, A., Wangh, L. J., and Allfrey, V. G. (1975) Science 190, 117-128[Free Full Text]
  6. Benson, L. J., Gu, Y., Yakovleva, T., Tong, K., Barrows, C., Strack, C. L., Cook, R. G., Mizzen, C. A., and Annunziato, A. T. (2006) J. Biol. Chem. 281, 9287-9296[Abstract/Free Full Text]
  7. Kuo, M. H., Brownell, J. E., Sobel, R. E., Ranalli, T. A., Cook, R. G., Edmondson, D. G., Roth, S. Y., and Allis, C. D. (1996) Nature 383, 269-272[CrossRef][Medline] [Order article via Infotrieve]
  8. Sobel, R. E., Cook, R. G., Perry, C. A., Annunziato, A. T., and Allis, C. D. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1237-1241[Abstract/Free Full Text]
  9. Ye, J., Ai, X., Eugeni, E. E., Zhang, L., Carpenter, L. R., Jelinek, M. A., Freitas, M. A., and Parthun, M. R. (2005) Mol. Cell 18, 123-130[CrossRef][Medline] [Order article via Infotrieve]
  10. Hyland, E. M., Cosgrove, M. S., Molina, H., Wang, D., Pandey, A., Cottee, R. J., and Boeke, J. D. (2005) Mol. Cell Biol. 25, 10060-10070[Abstract/Free Full Text]
  11. Masumoto, H., Hawke, D., Kobayashi, R., and Verreault, A. (2005) Nature 436, 294-298[CrossRef][Medline] [Order article via Infotrieve]
  12. Ozdemir, A., Spicuglia, S., Lasonder, E., Vermeulen, M., Campsteijn, C., Stunnenberg, H. G., and Logie, C. (2005) J. Biol. Chem. 280, 25949-25952[Abstract/Free Full Text]
  13. Recht, J., Tsubota, T., Tanny, J. C., Diaz, R. L., Berger, J. M., Zhang, X., Garcia, B. A., Shabanowitz, J., Burlingame, A. L., Hunt, D. F., Kaufman, P. D., and Allis, C. D. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 6988-6993[Abstract/Free Full Text]
  14. Xu, F., Zhang, K., and Grunstein, M. (2005) Cell 121, 375-385[CrossRef][Medline] [Order article via Infotrieve]
  15. Zhou, H., Madden, B. J., Muddiman, D. C., and Zhang, Z. (2006) Biochemistry 45, 2852-2861[CrossRef][Medline] [Order article via Infotrieve]
  16. Celic, I., Masumoto, H., Griffith, W. P., Meluh, P., Cotter, R. J., Boeke, J. D., and Verreault, A. (2006) Curr. Biol. 16, 1280-1289[CrossRef][Medline] [Order article via Infotrieve]
  17. Maas, N. L., Miller, K. M., DeFazio, L. G., and Toczyski, D. P. (2006) Mol. Cell 23, 109-119[CrossRef][Medline] [Order article via Infotrieve]
  18. Driscoll, R., Hudson, A., and Jackson, S. P. (2007) Science 315, 649-652[Abstract/Free Full Text]
  19. Han, J., Zhou, H., Horazdovsky, B., Zhang, K., Xu, R. M., and Zhang, Z. (2007) Science 315, 653-655[Abstract/Free Full Text]
  20. Schneider, J., Bajwa, P., Johnson, F. C., Bhaumik, S. R., and Shilatifard, A. (2006) J. Biol. Chem. 281, 37270-37274[Abstract/Free Full Text]
  21. Collins, S. R., Miller, K. M., Maas, N. L., Roguev, A., Fillingham, J., Chu, C. S., Schuldiner, M., Gebbia, M., Recht, J., Shales, M., Ding, H., Xu, H., Han, J., Ingvarsdottir, K., Cheng, B., Andrews, B., Boone, C., Berger, S. L., Hieter, P., Zhang, Z., Brown, G. W., Ingles, C. J., Emili, A., Allis, C. D., Toczyski, D. P., Weissman, J. S., Greenblatt, J. F., and Krogan, N. J. (2007) Nature 446, 806-810[CrossRef][Medline] [Order article via Infotrieve]
  22. Adkins, M. W., Carson, J. J., English, C. M., Ramey, C. J., and Tyler, J. K. (2007) J. Biol. Chem. 282, 1334-1340[Abstract/Free Full Text]
  23. Sipiczki, M. (2000) Genome. Biol. 1, REVIEWS 1011
  24. Arcangioli, B. (2000) EMBO Rep. 1, 145-150[Medline] [Order article via Infotrieve]
  25. Peters, A. H., Kubicek, S., Mechtler, K., O'Sullivan, R. J., Derijck, A. A., Perez-Burgos, L., Kohlmaier, A., Opravil, S., Tachibana, M., Shinkai, Y., Martens, J. H., and Jenuwein, T. (2003) Mol. Cell 12, 1577-1589[CrossRef][Medline] [Order article via Infotrieve]
  26. Zhang, L., Eugeni, E. E., Parthun, M. R., and Freitas, M. A. (2003) Chromosoma 112, 77-86[CrossRef][Medline] [Order article via Infotrieve]
  27. Redon, C., Pilch, D. R., and Bonner, W. M. (2006) Genetics 172, 67-76[Abstract/Free Full Text]
  28. Pommier, Y., Redon, C., Rao, V. A., Seiler, J. A., Sordet, O., Takemura, H., Antony, S., Meng, L., Liao, Z., Kohlhagen, G., Zhang, H., and Kohn, K. W. (2003) Mutat. Res. 532, 173-203[Medline] [Order article via Infotrieve]
  29. Moreno, S., Hayles, J., and Nurse, P. (1989) J. Cell Sci. Suppl. 12, 1-8[Medline] [Order article via Infotrieve]
  30. Koc, A., Wheeler, L. J., Mathews, C. K., and Merrill, G. F. (2004) J. Biol. Chem. 279, 223-230[Abstract/Free Full Text]
  31. Mellone, B. G., Ball, L., Suka, N., Grunstein, M. R., Partridge, J. F., and Allshire, R. C. (2003) Curr. Biol. 13, 1748-1757[CrossRef][Medline] [Order article via Infotrieve]
  32. Freeman-Cook, L. L., Sherman, J. M., Brachmann, C. B., Allshire, R. C., Boeke, J. D., and Pillus, L. (1999) Mol. Biol. Cell 10, 3171-3186[Abstract/Free Full Text]
  33. Djupedal, I., Portoso, M., Spahr, H., Bonilla, C., Gustafsson, C. M., Allshire, R. C., and Ekwall, K. (2005) Genes Dev. 19, 2301-2306[Abstract/Free Full Text]
  34. Nakayama, J., Allshire, R. C., Klar, A. J., and Grewal, S. I. (2001) EMBO J. 20, 2857-2866[CrossRef][Medline] [Order article via Infotrieve]
  35. Prado, F., Cortes-Ledesma, F., and Aguilera, A. (2004) EMBO Rep. 5, 497-502[CrossRef][Medline] [Order article via Infotrieve]
  36. Ramey, C. J., Howar, S., Adkins, M., Linger, J., Spicer, J., and Tyler, J. K. (2004) Mol. Cell. Biol. 24, 10313-10327[Abstract/Free Full Text]
  37. Kats, E. S., Albuquerque, C. P., Zhou, H., and Kolodner, R. D. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 3710-3715[Abstract/Free Full Text]
  38. Umehara, T., Chimura, T., Ichikawa, N., and Horikoshi, M. (2002) Genes Cells 7, 59-73[Abstract]
  39. Groth, A., Ray-Gallet, D., Quivy, J. P., Lukas, J., Bartek, J., and Almouzni, G. (2005) Mol. Cell 17, 301-311[CrossRef][Medline] [Order article via Infotrieve]
  40. Hu, F., Alcasabas, A. A., and Elledge, S. J. (2001) Genes Dev. 15, 1061-1066[Abstract/Free Full Text]
  41. Emili, A., Schieltz, D. M., Yates, J. R., III, and Hartwell, L. H. (2001) Mol. Cell 7, 13-20[CrossRef][Medline] [Order article via Infotrieve]
  42. Dalgaard, J. Z., and Klar, A. J. (1999) Nature 400, 181-184[CrossRef][Medline] [Order article via Infotrieve]
  43. Holmes, A. M., Kaykov, A., and Arcangioli, B. (2005) Mol. Cell. Biol. 25, 303-311[Abstract/Free Full Text]
  44. Kaykov, A., and Arcangioli, B. (2004) Curr. Biol. 14, 1924-1928[CrossRef][Medline] [Order article via Infotrieve]
  45. Vengrova, S., and Dalgaard, J. Z. (2004) Genes Dev. 18, 794-804[Abstract/Free Full Text]
  46. Lewis, L. K., Karthikeyan, G., Cassiano, J., and Resnick, M. A. (2005) Nucleic Acids Res. 33, 4928-4939[Abstract/Free Full Text]
  47. Davey, C. A., Sargent, D. F., Luger, K., Maeder, A. W., and Richmond, T. J. (2002) J. Mol. Biol. 319, 1097-1113[CrossRef][Medline] [Order article via Infotrieve]
  48. Franco, A. A., Lam, W. M., Burgers, P. M., and Kaufman, P. D. (2005) Genes Dev. 19, 1365-1375[Abstract/Free Full Text]
  49. Tomschik, M., Zheng, H., van Holde, K., Zlatanova, J., and Leuba, S. H. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 3278-3283[Abstract/Free Full Text]
  50. Li, G., Levitus, M., Bustamante, C., and Widom, J. (2005) Nat. Struct. Mol. Biol. 12, 46-53[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Biol. CellHome page
X. Yi, H. I. de Vries, K. Siudeja, A. Rana, W. Lemstra, J. F. Brunsting, R. M. Kok, Y. M. Smulders, M. Schaefer, F. Dijk, et al.
Stwl Modifies Chromatin Compaction and Is Required to Maintain DNA Integrity in the Presence of Perturbed DNA Replication
Mol. Biol. Cell, February 1, 2009; 20(3): 983 - 994.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
B. Yang, A. Miller, and A. L. Kirchmaier
HST3/HST4-dependent Deacetylation of Lysine 56 of Histone H3 in Silent Chromatin
Mol. Biol. Cell, November 1, 2008; 19(11): 4993 - 5005.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. Stavropoulos, V. Nagy, G. Blobel, and A. Hoelz
Molecular basis for the autoregulation of the protein acetyl transferase Rtt109
PNAS, August 26, 2008; 105(34): 12236 - 12241.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
D. Haldar and R. T. Kamakaka
Schizosaccharomyces pombe Hst4 Functions in DNA Damage Response by Regulating Histone H3 K56 Acetylation
Eukaryot. Cell, May 1, 2008; 7(5): 800 - 813.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Han, H. Zhou, Z. Li, R.-M. Xu, and Z. Zhang
Acetylation of Lysine 56 of Histone H3 Catalyzed by RTT109 and Regulated by ASF1 Is Required for Replisome Integrity
J. Biol. Chem., September 28, 2007; 282(39): 28587 - 28596.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/20/15040    most recent
M701197200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xhemalce, B.
Right arrow Articles by Arcangioli, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xhemalce, B.
Right arrow Articles by Arcangioli, B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement